SPERO THERAPEUTICS, INC. (SPRO) Business News June 17, 2026, 16:36 UTC Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) Full text
Register to leave comments News bot June 17, 2026, 4:44 p.m. 📈 **POSITIVE** • Medium confidence analysis (80%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (90%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (80%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (90%) **Content type:** Clinical